ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION
Loading...
  • 株式
  • /
  • ヘルスケア
1分前に更新
CCLD logo

CareCloud, Inc.NasdaqGM:CCLD 株式レポート

時価総額 US$87.1m
1分前に更新
株価
n/a
1Y-45.0%
7D-8.1%
1D0.5%
ポートフォリオ価値
​
表示

CareCloud, Inc.

NasdaqGM:CCLD 株式レポート

時価総額:US$87.1m

  • 会社概要
  • 評価
  • 将来の成長
  • 過去の実績
  • 財務の健全性
  • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

CareCloud(CCLD)株式概要

CareCloud, Inc.はヘルスケア情報技術企業で、主に米国のヘルスケアプロバイダーや病院に技術対応ビジネスソリューション、SaaS、関連ビジネスサービスを提供している。 詳細

CCLD ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長3/6
過去の実績5/6
財務の健全性3/6
配当金0/6

報酬

当社が推定した公正価値より86.9%で取引されている

収益は年間87.7%増加すると予測されています

過去1年間で収益は17288.2%増加しました

リスク分析

多額の負債を抱えている

意味のある時価総額がありません ( $87M )


CCLD Community Fair Values

Create Narrative

See what 37 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
67.5% 割安 内在価値ディスカウント
AnalystConsensusTarget
•4mo ago

Cloud EHR And AI Automation Will Unlock New Opportunities

184
0
11
AN
AnalystLowTarget
18.0% 割安 内在価値ディスカウント
AnalystLowTarget
•2mo ago

Rising Costs In Healthcare IT And Consolidation Will Squeeze Margins

93
0
4
AN
AnalystHighTarget
74.4% 割安 内在価値ディスカウント
AnalystHighTarget
•2mo ago

AI And Integrated Cloud Solutions Will Reshape Care Delivery

98
0
8

Top Analyst Narratives

AN
AnalystConsensusTarget
67.5% 割安 内在価値ディスカウント
AnalystConsensusTarget
•4mo ago

Cloud EHR And AI Automation Will Unlock New Opportunities

184
0
11
AN
AnalystLowTarget
18.0% 割安 内在価値ディスカウント
AnalystLowTarget
•2mo ago

Rising Costs In Healthcare IT And Consolidation Will Squeeze Margins

93
0
4
AN
AnalystHighTarget
74.4% 割安 内在価値ディスカウント
AnalystHighTarget
•2mo ago

AI And Integrated Cloud Solutions Will Reshape Care Delivery

98
0
8
View all narratives

CareCloud, Inc. 競合他社

OptimizeRx

Symbol: NasdaqCM:OPRX
Market cap: US$137.3m

Simulations Plus

Symbol: NasdaqGS:SLP
Market cap: US$372.5m

Phreesia

Symbol: NYSE:PHR
Market cap: US$640.0m

HealthStream

Symbol: NasdaqGS:HSTM
Market cap: US$851.2m

価格と性能

株価の高値、安値、推移の概要CareCloud
過去の株価
現在の株価US$2.05
52週高値US$3.85
52週安値US$2.03
ベータ1.5
1ヶ月の変化-20.85%
3ヶ月変化-8.48%
1年変化-45.04%
3年間の変化58.91%
5年間の変化-74.57%
IPOからの変化-52.10%

最新ニュース

分析記事 • Aug 09

CareCloud, Inc. (NASDAQ:CCLD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

It's been a good week for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, because the company has just released its...
User avatar
ナラティブ更新 • Jul 01

CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion

Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.

Recent updates

分析記事 • Aug 09

CareCloud, Inc. (NASDAQ:CCLD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

It's been a good week for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, because the company has just released its...
User avatar
ナラティブ更新 • Jul 01

CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion

Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.
User avatar
ナラティブ更新 • Jun 16

CCLD: Balance Sheet Reshaping And 2026 Guidance Will Support Bullish Repricing

Analysts have adjusted their price target on CareCloud to $8.00, reflecting updated assumptions around revenue growth, profit margins, discount rate and future P/E that they consider better aligned with the company’s current outlook. What’s in the News for CareCloud CareCloud fully redeemed all outstanding 8.75% Series B Preferred Stock, funded with a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank.
User avatar
ナラティブ更新 • Jun 02

CCLD: Capital Reshaping And 2026 Outlook Will Clarify Underlying Revenue Trends

Analysts have reduced their price target on CareCloud to $3.25, citing concern that recent acquisitions, including plans to acquire an aircraft for client visits, may be obscuring underlying revenue declines. What's in the News CareCloud redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank, as part of a multi year capital structure shift.
User avatar
ナラティブ更新 • May 13

CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential

Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.
分析記事 • May 11

The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts

There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...
User avatar
ナラティブ更新 • Apr 29

CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence

Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.
User avatar
ナラティブ更新 • Apr 14

CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending

Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.
User avatar
ナラティブ更新 • Mar 31

CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential

Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.
User avatar
ナラティブ更新 • Mar 17

CCLD: Higher Margins And New Contracts Will Support Future Upside

Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.
User avatar
ナラティブ更新 • Mar 02

CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside

Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.
User avatar
ナラティブ更新 • Feb 16

CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential

Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.
分析記事 • Feb 04

Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)

You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...
User avatar
ナラティブ更新 • Feb 02

CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential

Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.
Seeking Alpha • Jan 29

CareCloud: Undervalued AI Play In Healthcare IT

Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking Alpha
User avatar
ナラティブ更新 • Jan 19

CCLD: Cost Controls And AI Automation Will Support Future Repricing

Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.
User avatar
ナラティブ更新 • Jan 05

CCLD: Cost Controls And New AI Offering Will Support Future Upside

Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.
User avatar
ナラティブ更新 • Dec 15

CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher

Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.
User avatar
ナラティブ更新 • Dec 01

CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum

CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.
User avatar
ナラティブ更新 • Nov 17

CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability

CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.
分析記事 • Aug 26

There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise

Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...
分析記事 • May 01

There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise

Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...
User avatar
新しいナラティブ • Apr 12

CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities

AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.
分析記事 • Mar 16

Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report

There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...
分析記事 • Mar 13

Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%

CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...
分析記事 • Feb 19

CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
分析記事 • Jan 18

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%

CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...
分析記事 • Nov 13

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth

CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...
分析記事 • Oct 07

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Aug 31

CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth

CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
分析記事 • Jul 13

CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...
分析記事 • Jun 27

We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • May 22

CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%

CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Mar 22

CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate

Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...
分析記事 • Mar 22

The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%

CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...
分析記事 • Feb 02

Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding

The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...
分析記事 • Jan 30

Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Dec 19

CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues

CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...
分析記事 • Sep 28

Is CareCloud (NASDAQ:CCLD) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

株主還元

CCLDUS Healthcare ServicesUS 市場
7D-8.1%-4.1%-0.9%
1Y-45.0%-18.2%14.2%

業界別リターン: CCLD過去 1 年間で-18.2 % の収益を上げたUS Healthcare Services業界を下回りました。

リターン対市場: CCLDは、過去 1 年間で14.2 % のリターンを上げたUS市場を下回りました。

価格変動

Is CCLD's price volatile compared to industry and market?
CCLD volatility
CCLD Average Weekly Movement9.1%
Healthcare Services Industry Average Movement9.9%
Market Average Movement6.9%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market2.9%

安定した株価: CCLD 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。

時間の経過による変動: CCLDの 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
19993,650Stephen Snyderwww.carecloud.com

ヘルスケアIT企業であるCareCloud, Inc.は、主に米国のヘルスケアプロバイダーや病院向けに、テクノロジー対応のビジネスソリューション、SaaS、関連ビジネスサービスを提供している。ヘルスケアIT部門とメディカル・プラクティス・マネジメント部門を通じて事業を展開している。同社独自のソフトウェアおよびビジネスサービスには、テクノロジー対応ビジネスソリューション、クラウドベースのソフトウェア、デジタルヘルスサービス、ヘルスケアITプロフェッショナルサービスおよび人材派遣、MAP App、診療管理サービスなどがある。また、収益サイクル管理サービス、医療費請求クリアリングハウス、医療コーディングおよび資格認定サービス、電子カルテ、診療管理ソフトウェアおよび関連機能、患者エクスペリエンス管理ソリューション、ビジネスインテリジェンスおよび医療分析プラットフォーム、カスタマイズされたアプリケーション、インターフェース、その他さまざまなテクノロジーソリューションのほか、AIを活用した臨床判断サポート、AIを活用したバーチャルサポートアシスタント、AIを活用したアピール、Stratus AI Desk Agent、CareCloud cirrusAIなどの人工知能も提供している。また、慢性期ケアマネジメント、遠隔患者モニタリング、遠隔医療ソリューション、プロフェッショナルサービス、マネージドサービス、人員増強、オンデマンドスタッフィング、戦略的アドバイザリーサービスを提供している。さらに、適切な施設、設備、備品、サポートサービス、看護師、管理サポートスタッフからなる医療行為管理サービスや、管理、請求書支払い、財務アドバイザリーサービスも提供している。同社は、医師、看護師、ナース・プラクティショナー、セラピスト、医師助手、その他診療報酬を請求する臨床医にサービスを提供している。同社は以前はMTBC, Inc.として知られていたが、2021年3月に社名をCareCloud, Inc.に変更した。CareCloud, Inc.は1999年に設立され、ニュージャージー州サマセットに本社を置いている。

CareCloud, Inc. 基礎のまとめ

CareCloud の収益と売上を時価総額と比較するとどうか。
CCLD 基礎統計学
時価総額US$87.11m
収益(TTM)US$2.96m
売上高(TTM)US$128.64m
29.5x
PER(株価収益率
0.7x
P/Sレシオ

CCLD は割高か?

公正価値と評価分析を参照

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
CCLD 損益計算書(TTM)
収益US$128.64m
売上原価US$68.82m
売上総利益US$59.82m
その他の費用US$56.87m
収益US$2.96m

直近の収益報告

Jun 30, 2026

次回決算日

該当なし

一株当たり利益(EPS)0.07
グロス・マージン46.50%
純利益率2.30%
有利子負債/自己資本比率281.5%

CCLD の長期的なパフォーマンスは?

過去の実績と比較を見る

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/13 18:31
終値2026/09/11 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

CareCloud, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8

アナリスト機関
Marc WiesenbergerB. Riley Securities, Inc.
Keay NakaeChardan Capital Markets, LLC
Eugene MannheimerColliers Securities

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド